• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate (CAS No. 1221188-46-0): A Comprehensive Overview

Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate (CAS No. 1221188-46-0) is a significant compound in the field of pharmaceutical chemistry, known for its versatile applications in drug discovery and development. This compound, characterized by its unique structural and chemical properties, has garnered considerable attention due to its potential in various therapeutic areas.

The molecular structure of Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate consists of a thiazole core substituted with a trifluoromethyl group and a carboxylate ester at the 2-position, linked to an ethyl group. This specific arrangement imparts distinct physicochemical properties, making it a valuable building block for synthesizing novel bioactive molecules. The presence of the trifluoromethyl group enhances lipophilicity and metabolic stability, which are crucial factors in drug design.

In recent years, there has been a surge in research focusing on heterocyclic compounds, particularly thiazole derivatives, due to their broad spectrum of biological activities. Studies have demonstrated that thiazole-based compounds exhibit antimicrobial, anti-inflammatory, anticancer, and antiviral properties. Among these, Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate has shown promise as a lead compound in developing new therapeutic agents.

One of the most compelling aspects of Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate is its role in the synthesis of targeted small molecules for treating complex diseases. Researchers have leveraged its structural framework to develop inhibitors of key enzymes involved in cancer progression. For instance, derivatives of this compound have been investigated for their ability to inhibit kinases and other enzymes that play critical roles in tumor growth and metastasis.

The trifluoromethyl group in the molecule is particularly noteworthy, as it significantly influences the pharmacokinetic profile of the compound. This moiety enhances binding affinity to biological targets and improves resistance to metabolic degradation. Such properties make Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate an attractive candidate for further optimization into potent drug candidates.

Recent advancements in computational chemistry have enabled more efficient screening and design of thiazole derivatives like Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate. Molecular docking studies have identified novel binding pockets on target proteins, providing insights into how these compounds interact at the molecular level. These findings have guided the development of more refined analogs with improved efficacy and reduced side effects.

The pharmaceutical industry has also recognized the potential of Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate in addressing unmet medical needs. Several companies are currently exploring its use in developing treatments for neurological disorders, infectious diseases, and chronic conditions. The compound's ability to modulate multiple biological pathways makes it a versatile tool for drug discovery.

In conclusion, Ethyl 5-(trifluoromethyl)thiazole-2-carboxylate (CAS No. 1221188-46-0) represents a promising candidate in pharmaceutical research due to its unique structural features and broad range of biological activities. Ongoing studies continue to uncover new applications for this compound, reinforcing its importance in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)